Australia's most trusted
source of pharma news
Saturday, 07 February 2026
Posted 6 February 2026 PM
GSK's new Australian CEO, Luke Miels, has delivered his first earnings results as head of the company and unveiled his game plan for GSK's future success.
The Aussie high-flyer has quickly put his own stamp on the job, outlining how he intends to achieve the company's ambitious target of total sales of AU$82 billion in the next five years.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.